Editas Medicine Names Bernadette Connaughton to Board of Directors
Bernadette Connaughton Editas Medicine announced that it has appointed Bernadette Connaughton to its Board of Directors. CAMBRIDGE, Mass., Oct. 28, 2021...
News
Ontario company announces state-of-the-art COVID protection
COLLINGWOOD, Ontario, Oct. 28, 2021 (GLOBE NEWSWIRE) -- As the fourth -- and potentially subsequent -- waves of COVID hit...
Reflect Scientific Inc. Successfully Up-lists to OTCQB Venture Market
OREM, Utah, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants
MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company...
Albireo to Report Third Quarter 2021 Financial Results on November 4
— Conference call and webcast to be held at 10:00 a.m. ET —BOSTON, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Albireo...
Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer
30-year healthcare and technology veteran with extensive global executive experience and diverse expertise in R&D, commercialization, product management, digital innovation...
Allogene Therapeutics to Report Third Quarter Financial Results on November 4, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) --...
Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
FOSTER CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve...
Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal
NEW YORK and SYDNEY, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the...
Entera Bio Publishes Key Study Describing its Oral Delivery Technology Platform for Biologic Drugs
‒Study describes a dual mechanism of action approach to oral drug delivery of large molecules, the “Holy Grail” of drug...
Spero Therapeutics Submits New Drug Application to U.S. FDA for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying,...
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients
IRVINE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on...
Jounce Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call on Thursday, November 4, 2021
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
Immutep Quarterly Activities Report & Appendix 4C
Received competent authority and institutional review board approvals for TACTI-003 Phase IIb trialEnrolled first patient in INSIGHT-003 study in patients...
Gain Therapeutics to Present at Upcoming Medical Conferences
- The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Webinars - - Society of Neuroscience 50th Anniversary Meeting – BETHESDA,...
Revolo Biotherapeutics Activates Clinical Sites and Opens Enrollment in a Phase 2 Clinical Trial of ‘1104 in Eosinophilic Esophagitis
NEW ORLEANS and LONDON, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...
Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services
Pinnacle 21 Enterprise software expedites regulatory review of all study submission dataPRINCETON, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Certara,...
Caladrius Biosciences to Host Third Quarter 2021 Financial Results Conference Call on Thursday, November 4th at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical...
CytomX Therapeutics to Announce Third Quarter 2021 Financial Results on November 4, 2021
SOUTH SAN FRANCISCO, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
Galecto Hosting a Key Opinion Leader Webinar on GB1211: A Potential Treatment For Non-Small Cell Lung Cancer
Monday, November 8th @ 10:30am ETBOSTON, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology...
